VeriMom¿Es acetyl farnesylcysteine seguro durante el embarazo?
No harmonised CLP classification, no SCCS or CIR safety assessment found for acetyl farnesylcysteine; peer‑reviewed literature shows topical/local anti‑inflammatory activity in skin models (mouse topical studies and human dermal cell studies) but no reproductive or developmental toxicity data were identified, so hazard and mechanism scores default to 0. Topical use has measurable but likely low systemic absorption in the published pharmacology/skin studies, so exposure is scored as 1. (Sources: PubMed topical/in vitro studies; absence of harmonised CLP/SCCS/CIR entries in searches).
Related ingredients
Frequently asked questions
- ¿Es acetyl farnesylcysteine seguro durante el embarazo?
- No harmonised CLP classification, no SCCS or CIR safety assessment found for acetyl farnesylcysteine; peer‑reviewed literature shows topical/local anti‑inflammatory activity in skin models (mouse topical studies and human dermal cell studies) but no reproductive or developmental toxicity data were identified, so hazard and mechanism scores default to 0. Topical use has measurable but likely low systemic absorption in the published pharmacology/skin studies, so exposure is scored as 1. (Sources: PubMed topical/in vitro studies; absence of harmonised CLP/SCCS/CIR entries in searches).
- ¿Es acetyl farnesylcysteine seguro durante la lactancia?
- No evidence of reproductive or lactation‑related toxicity in the scientific literature or regulatory assessments. Dermal application to the breast could lead to low but measurable maternal systemic exposure (as for pregnancy), so exposure given as 1; no data show transfer into breastmilk or effects on nursing infants.
- ¿Es acetyl farnesylcysteine seguro para la piel del bebé?
- No infant‑specific toxicology found. Because topical AFC shows measurable activity/absorption in skin studies, baby exposure is increased by +1 to account for immature barrier and higher surface‑area‑to‑weight (adult e=1 → infant e=2). No data indicate infant‑specific hazard or mechanisms, so h and m remain 0.
- ¿Cómo puntúa VeriMom a acetyl farnesylcysteine?
- VeriMom puntúa acetyl farnesylcysteine en 93/100 (sin riesgos conocidos) según el estado EU CosIng, clasificaciones ECHA y estudios PubMed.
- ¿Cuáles son las alternativas seguras a acetyl farnesylcysteine en el embarazo?
- Consulta nuestra lista de alternativas seguras a acetyl farnesylcysteine según función similar y clasificación sin riesgos conocidos.
Comprueba cualquier etiqueta en 2 segundos
Descarga VeriMom gratis — escanea cualquier producto y ve la puntuación de seguridad en el embarazo al instante.
Aviso Médico
Esta información es solo para fines educativos y no constituye asesoramiento médico. Las puntuaciones de seguridad se basan en datos disponibles públicamente y pueden no reflejar todos los riesgos. Siempre consulte a su profesional de salud antes de usar cualquier producto durante el embarazo o la lactancia.